Embla Medical
EMBLA.CO
#4207
Rank
C$2.99 B
Marketcap
$7.01
Share price
-1.10%
Change (1 day)
27.37%
Change (1 year)
Categories

P/E ratio for Embla Medical (EMBLA.CO)

P/E ratio as of November 2024 (TTM): 43.9

According to Embla Medical's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 43.8966. At the end of 2023 the company had a P/E ratio of 28.2.

P/E ratio history for Embla Medical from 2011 to 2024

PE ratio at the end of each year

Year P/E ratio Change
202328.2-39.81%
202246.820.13%
202139.0-91.75%
2020473880.78%
201948.299.48%
201824.2-15.36%
201728.6-8.41%
201631.25.2%
201529.653.69%
201419.316.21%
201316.630.98%
201212.7-20.66%
201116.0

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.